?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
518 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
518 Unternehmen gefunden • Seite 3 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Anhui Anke BioTech Group | 73.4 | Arzneimittel (Pharmazeutisch) | China | 2.0 Mrd. USD | 19.04 | 129.87 | 5.44 | 3.13 | ▲ 9.24% | ▲ 15.42% | 3.13% | ▲ 8.45% | - | 27.78% | ▲ 3.42% | 31.78% | ▲ 3.18% | 27.82% | ▲ 2.59% | 7 / 9 | 10,23 | > 50-fach | 37 / 100 | −2,4 / 100 | −3,12 |
| Center Laboratories | 73.0 | Arzneimittel (Pharmazeutisch) | Taiwan | 0.8 Mrd. USD | 23.48 | 190.84 | 14.44 | 1.39 | ▲ 16.16% | ▲ 19.75% | 5.77% | ▲ 10.21% | - | 614.89% | ▲ 51.02% | -23.88% | ▼ -46.82% | -11.94% | ▲ 16.11% | 5 / 9 | 6,22 | 16-fach | 2 / 100 | 26,8 / 100 | −0,75 |
| ALTEOGEN Inc | 72.8 | Arzneimittel (Biotechnologie) | Südkorea | 13.1 Mrd. USD | 97.25 | 326.94 | 73.39 | 34.75 | ▲ 38.45% | - | 0.11% | - | - | 65.63% | ▲ 19.09% | 49.52% | ▲ 18.96% | 42.02% | ▲ 30.83% | 8 / 9 | 6,93 | 17-fach | 24 / 100 | 2,5 / 100 | −2,30 |
 | Daiichi Sankyo Co Ltd ADR | 72.3 | Arzneimittel (Pharmazeutisch) | Japan | 32.9 Mrd. USD | 20.50 | 2008.31 | 2.24 | 2.99 | ▲ 18.52% | ▲ 29.40% | 2.71% | ▼ -56.50% | - | 12.24% | ▲ 1.88% | 9.76% | ▲ 1.37% | -2.39% | ▼ -2.75% | 5 / 9 | 4,55 | 34-fach | 38 / 100 | 4,8 / 100 | −1,98 |
| Beijing Tiantan Biological Products Corp Ltd | 72.2 | Arzneimittel (Biotechnologie) | China | 3.6 Mrd. USD | 31.57 | - | 4.24 | 2.00 | ▲ 12.24% | ▲ 11.29% | 1.65% | - | - | 17.77% | ▲ 0.36% | 28.77% | ▲ 0.58% | -3.74% | ▲ 0.11% | 5 / 9 | 16,46 | > 50-fach | 20 / 100 | 5,5 / 100 | −0,89 |
| China Resources Sanjiu Medical & Pharmaceutical Co Ltd | 71.9 | Arzneimittel (Pharmazeutisch) | China | 5.9 Mrd. USD | 12.13 | 29.19 | 1.25 | 1.74 | ▲ 18.30% | ▲ 16.46% | 5.38% | - | - | 10.83% | ▼ -0.61% | 15.35% | ▼ -0.12% | 13.42% | ▲ 1.55% | 9 / 9 | 5,36 | 46-fach | 40 / 100 | −5,0 / 100 | −2,64 |
 | Amgen Inc | 71.9 | Arzneimittel (Biotechnologie) | USA | 204.0 Mrd. USD | 23.33 | 20.05 | 5.35 | 17.45 | ▲ 7.64% | ▲ 1.20% | 2.64% | ▲ 7.44% | 14 Jahre | 20.99% | ▼ -1.60% | 29.06% | ▼ -1.53% | 22.05% | ▼ -2.27% | 8 / 9 | 0,34 | 3-fach | 29 / 100 | −2,5 / 100 | −2,35 |
 | Aurinia Pharmaceuticals Inc | 71.5 | Arzneimittel (Biotechnologie) | Kanada | 2.1 Mrd. USD | 6.82 | 12.34 | 6.88 | 3.48 | ▲ 41.38% | - | - | - | - | 101.47% | ▲ 107.97% | 37.06% | ▲ 94.79% | 47.84% | ▲ 87.21% | 8 / 9 | 5,30 | 5-fach | 33 / 100 | 20,2 / 100 | 2,39 |
 | Gyre Therapeutics Inc. | 71.3 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | - | - | 5.98 | 5.47 | ▲ 40.96% | - | - | - | - | 4.31% | ▲ 241.44% | 9.86% | ▲ 230.80% | -0.15% | ▲ 229.34% | 5 / 9 | 7,94 | - | 86 / 100 | 3,1 / 100 | −6,33 |
 | Regeneron Pharmaceuticals Inc | 71.1 | Arzneimittel (Biotechnologie) | USA | 80.5 Mrd. USD | 18.59 | 22.85 | 5.18 | 2.54 | ▲ 11.04% | ▲ 5.10% | 0.48% | - | - | 31.41% | ▼ -4.22% | 24.95% | ▼ -7.76% | 28.45% | ▼ -3.49% | 5 / 9 | 9,49 | > 50-fach | 30 / 100 | −1,2 / 100 | −2,55 |
| China Resources Double-Crane Pharmaceutical Co Ltd | 70.8 | Arzneimittel (Pharmazeutisch) | China | 2.5 Mrd. USD | 10.16 | 80.39 | 1.51 | 1.34 | ▲ 5.28% | ▲ 10.38% | 3.03% | ▲ 24.40% | 1 Jahre | 14.97% | ▲ 1.17% | 16.86% | ▲ 1.03% | 7.91% | ▼ -0.07% | 5 / 9 | 7,27 | > 50-fach | 40 / 100 | 1,0 / 100 | −2,16 |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 70.8 | Arzneimittel (Pharmazeutisch) | China | 37.1 Mrd. USD | 38.72 | - | 10.41 | 3.86 | - | - | 0.42% | - | - | 24.38% | ▲ 1.81% | 27.18% | ▲ 3.14% | 26.16% | ▲ 5.55% | 5 / 9 | 14,97 | > 50-fach | 39 / 100 | −5,1 / 100 | −2,74 |
 | Veracyte Inc | 70.7 | Arzneimittel (Biotechnologie) | USA | 3.3 Mrd. USD | 28.70 | 19.86 | 5.85 | 2.37 | ▲ 34.50% | - | - | - | - | 12.83% | ▲ 11.23% | 14.34% | ▲ 12.08% | 24.49% | ▲ 9.73% | 7 / 9 | 15,71 | > 50-fach | 26 / 100 | −5,0 / 100 | −2,61 |
| Shanghai Kaibao Pharmaceutical | 70.5 | Arzneimittel (Pharmazeutisch) | China | 0.8 Mrd. USD | 20.51 | 30.66 | 5.25 | 1.24 | ▲ 4.89% | ▲ 21.29% | 2.56% | ▲ 27.23% | 4 Jahre | 24.17% | ▲ 3.13% | 23.64% | ▲ 2.54% | 17.67% | ▼ -0.13% | 5 / 9 | 17,71 | > 50-fach | 19 / 100 | 1,0 / 100 | −3,67 |
 | Zealand Pharma A/S | 70.5 | Arzneimittel (Biotechnologie) | Dänemark | 2.9 Mrd. USD | 6.87 | - | 4.06 | 1.05 | ▲ 91.98% | - | - | - | - | 70.05% | ▲ 4.38% | 77.66% | ▼ -37.08% | 70.52% | ▲ 39.63% | 8 / 9 | 18,40 | 49-fach | 56 / 100 | −0,5 / 100 | 4,53 |
| Dashenlin Pharm Grp Co Ltd | 70.4 | Arzneimittel (Pharmazeutisch) | China | 3.0 Mrd. USD | 14.78 | 93.41 | 0.72 | 2.61 | ▲ 13.53% | ▲ 3.06% | 4.69% | ▲ 21.94% | - | 4.49% | ▼ -0.19% | 7.62% | ▲ 0.12% | 17.69% | ▲ 2.56% | 6 / 9 | 1,09 | 8-fach | 37 / 100 | −16,3 / 100 | −3,52 |
 | Harmony Biosciences Holdings | 70.4 | Arzneimittel (Pharmazeutisch) | USA | 2.4 Mrd. USD | 13.34 | 6.81 | 2.52 | 2.42 | ▲ 40.30% | - | - | - | - | 18.27% | ▼ -0.72% | 24.00% | ▼ -1.01% | 40.06% | ▲ 1.34% | 5 / 9 | 7,28 | 11-fach | 53 / 100 | −14,9 / 100 | −3,21 |
 | Oramed Pharmaceuticals Inc | 70.2 | Arzneimittel (Pharmazeutisch) | USA | 0.2 Mrd. USD | - | - | 96.92 | 1.38 | ▼ -5.85% | - | 5.36% | - | - | 3202.50% | ▲ 848.95% | -754.40% | ▼ -92.18% | -553.90% | ▼ -17.34% | 5 / 9 | 10,43 | 8-fach | 0 / 100 | 31,7 / 100 | - |
| Livzon Pharmaceutical Group Inc | 70.2 | Arzneimittel (Pharmazeutisch) | China | 3.5 Mrd. USD | 14.12 | 21.74 | 2.20 | 1.77 | ▲ 2.51% | ▲ 3.36% | 5.37% | ▲ 2.73% | - | 16.99% | ▲ 0.69% | 22.03% | ▲ 1.20% | 21.87% | ▲ 3.98% | 9 / 9 | 7,19 | 32-fach | 35 / 100 | −5,2 / 100 | −3,46 |
 | TG Therapeutics Inc | 70.1 | Arzneimittel (Biotechnologie) | USA | 8.3 Mrd. USD | 18.68 | - | 10.32 | 13.66 | ▲ 426.73% | - | - | - | - | 72.56% | ▲ 1711.87% | 20.01% | ▲ 1820.03% | -4.05% | ▲ 1515.71% | 4 / 9 | 2,11 | 3-fach | 48 / 100 | 44,4 / 100 | 4,34 |
 | MiMedx Group Inc | 70.1 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | 106.93 | 16.44 | 1.88 | 3.09 | ▲ 11.02% | - | - | - | - | 11.60% | ▲ 5.51% | 15.26% | ▲ 5.87% | 17.43% | ▲ 6.53% | 8 / 9 | 8,14 | 18-fach | 101 / 100 | −7,4 / 100 | −2,71 |
| Hualan Biological EngineeringInc | 69.3 | Arzneimittel (Biotechnologie) | China | 3.5 Mrd. USD | 28.93 | 35.92 | 5.36 | 2.13 | ▼ -1.85% | ▼ -10.23% | 9.38% | ▲ 10.76% | 1 Jahre | 20.55% | ▼ -1.64% | 24.68% | ▼ -2.71% | 20.64% | ▲ 1.92% | 7 / 9 | 12,55 | > 50-fach | 19 / 100 | −1,5 / 100 | −2,79 |
 | BeOne Medicines AG | 69.1 | Arzneimittel (Biotechnologie) | Schweiz | 38.7 Mrd. USD | 59.03 | 29.45 | 6.32 | 7.47 | ▲ 76.90% | - | - | - | - | 5.37% | ▲ 38.32% | 8.37% | ▲ 37.28% | 17.63% | ▲ 41.19% | 7 / 9 | 1,80 | −10,1-fach | 56 / 100 | −10,3 / 100 | −2,89 |
 | H Lundbeck A/S | 69.0 | Arzneimittel (Pharmazeutisch) | Dänemark | 6.8 Mrd. USD | 11.36 | 9.50 | 1.72 | 1.64 | ▲ 6.63% | ▲ 15.09% | 2.59% | - | 2 Jahre | 13.11% | ▲ 1.38% | 26.05% | ▲ 2.67% | 17.84% | ▲ 1.31% | 5 / 9 | 3,49 | 15-fach | 36 / 100 | −3,2 / 100 | −2,37 |
 | Theravance Biopharma Inc | 69.0 | Arzneimittel (Pharmazeutisch) | USA | 0.9 Mrd. USD | 16.41 | 17.04 | 8.47 | 3.05 | ▲ 8.38% | - | - | - | - | 98.54% | ▼ -86.80% | -12.33% | ▲ 101.36% | 221.93% | ▲ 155.46% | 8 / 9 | 2,84 | 6-fach | 21 / 100 | −27,3 / 100 | −3,84 |
